0

Journal Articles

in Toxicology
 81-100 of 703 Articles
JAMA | 
Medical News and Perspectives |  January 18, 2012
Poisonings Top Crashes for Injury-Related Deaths
Bridget M. Kuehn
JAMA. 2012;307(3):242. doi:10.1001/jama.2011.1998.
JAMA | 
Medical News and Perspectives |  January 04, 2012
Scientists, Officials Eye Tools Aimed at Combating Abuse of Painkillers
Bridget M. Kuehn
JAMA. 2012;307(1):19-21. doi:10.1001/jama.2011.1900.
JAMA | 
From the Centers for Disease Control and Prevention |  January 04, 2012 FREE
Paralytic Shellfish Poisoning—Southeast Alaska, May—June 2011
JAMA. 2012;307(1):29-31. doi:.
JAMA | 
Health Agencies Update |  December 28, 2011
Serotonin Syndrome Update
Bridget M. Kuehn
JAMA. 2011;306(24):2661. doi:10.1001/jama.2011.1868.
JAMA | 
From the Centers for Disease Control and Prevention |  December 14, 2011 FREE
Vital Signs: Overdoses of Prescription Opioid Pain Relievers—United States, 1999-2008
JAMA. 2011;306(22):2444-2446. doi:.
JAMA | 
Lab Reports |  December 07, 2011
New Antimicrobials
Tracy Hampton, PhD
JAMA. 2011;306(21):2315. doi:10.1001/jama.2011.1740.
JAMA Dermatology | 
Evidence-Based Dermatology: Critically Appraised Topic |  December 01, 2011 FREE
In a Patient With Toxic Epidermal Necrolysis, Does Intravenous Immunoglobulin Improve Survival Compared With Supportive Care?
Catriona Isobel Wootton, MBChB, MA(Hons); Anand Neel Patel, BMedSci, BMBS, MRCP; Hywel C. Williams, MSc, PhD, FRCP
Arch Dermatol. 2011;147(12):1437-1440. doi:10.1001/archdermatol.2011.300.
JAMA Dermatology | 
Practice Gaps |  December 01, 2011
Use of Intravenous Immunoglobulin in Toxic Epidermal Necrolysis:  Comment on “In a Patient With Toxic Epidermal Necrolysis, Does Intravenous Immunoglobulin Improve Survival Compared With Supportive Care? ”
Laurence Feldmeyer, MD, PhD; Francisco A. Kerdel, MD; Lars E. French, MD
Arch Dermatol. 2011;147(12):1440-1441. doi:10.1001/archdermatol.2011.1610.
JAMA Dermatology | 
Study |  December 01, 2011 FREE
Economic Burden of Dermatologic Adverse Events Induced by Molecularly Targeted Cancer Agents
Judy H. Borovicka, MD; Cara Calahan, RN; Mona Gandhi, MD; et al.
Arch Dermatol. 2011;147(12):1403-1409. doi:10.1001/archdermatol.2011.719.
JAMA Neurology | 
Correspondence |  December 01, 2011
Central Nervous System Problems With Eosinophilia
Peter W. Kaplan, MB, BS, FRCP(UK)
Arch Neurol. 2011;68(12):1613-1614. doi:10.1001/archneur.68.12.1613.
JAMA | 
JAMA Clinical Challenge |  November 23, 2011 FREE
Acute-Onset Reticulated White Lip
Jeffery B. Shackelton, MD; Joseph C. English, MD
JAMA. 2011;306(20):2267-2268. doi:10.1001/jama.2011.1728.
JAMA Internal Medicine | 
Editor's Correspondence |  November 08, 2011
Identifying Patients With Cocaine-Related Chest Pain at True Risk for β-Blocker Toxicity
Joshua Canning, MD; Daniel E. Brooks, MD; Richard D. Gerkin, MD
Arch Intern Med. 2011;170(20):1859. doi:10.1001/archinternmed.2010.397.
JAMA Dermatology | 
Correspondence |  November 01, 2011
Multiple Bites From the Larvae of Haemaphysalis longicornis
Young Bok Lee, MD; Jae Bok Jun, MD; Jun Young Kim, MD; et al.
Arch Dermatol. 2011;147(11):1333-1334. doi:10.1001/archdermatol.2011.328.
JAMA | 
Health Agencies Update |  October 26, 2011
Overdoses on the Rise
Bridget M. Kuehn
JAMA. 2011;306(16):1750. doi:10.1001/jama.2011.1539.
JAMA | 
Global Health |  October 19, 2011
Blood Lead Levels
M. J. Friedrich
JAMA. 2011;306(15):1644. doi:10.1001/jama.2011.1484.
JAMA | 
Lab, Field, and Clinic |  October 12, 2011
New Model System Offers Clues to ALS
Bridget M. Kuehn
JAMA. 2011;306(14):1534. doi:10.1001/jama.2011.1439.
JAMA Internal Medicine | 
Research Letters |  October 10, 2011 FREE
Deaths Involving Drugs in Vermont, 2004 Through 2010
Erika M. Edwards, PhD, MPH; John S. Searles, PhD; Steven L. Shapiro, MD
Arch Intern Med. 2011;171(18):1676-1678. doi:10.1001/archinternmed.2011.450.
JAMA Neurology | 
Original Contributions |  October 01, 2011
Continuous Epileptiform Discharges in Patients Treated With Cefepime or Meropenem
Gilles Naeije, MD; Sophie Lorent, MPharm; Jean-Louis Vincent, MD, PhD; et al.
Arch Neurol. 2011;68(10):1303-1307. doi:10.1001/archneurol.2011.204.
JAMA | 
Health Agencies Update |  September 28, 2011
Treatment for Scorpion Stings
Bridget M. Kuehn
JAMA. 2011;306(12):1315. doi:10.1001/jama.2011.1377.
JAMA | 
Commentary |  August 10, 2011
Genomic Technology Applied to Pharmacological Traits
Jun J. Yang, PhD; Robert M. Plenge, MD, PhD
JAMA. 2011;306(6):652-653. doi:10.1001/jama.2011.1125.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Editor's Correspondence  |  June 10, 2013
Comment Regarding the Stability of Active Ingredients in Long-Expired Prescription Medications
Michael M. Madden, PhD; Frank M. Etzler, PhD; Thomas Gant, PhD
JAMA Neurology
Observation  |  June 10, 2013
Serotonin Syndrome Associated With Clozapine Withdrawal
Elizabeth Stevenson, MD, MS; Frank Schembri, MD; Deborah M. Green, MD; et al.
JAMA
Viewpoint  |  May 9, 2013
Opioid Analgesics—Risky Drugs, Not Risky Patients
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA
News From the Centers for Disease Control and Prevention  |  June 05, 2013
NIOSH Warns of Nanomaterials’ Health Risks
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems